Epstein-Barr virus-associated B-cell lymphoproliferative disorder in CLL patients after treatment with fludarabine and cyclophosphamide followed by high-dose chemotherapy with autologous stem cell transplantation

Bone Marrow Transplant. 2003 May;31(10):951-2. doi: 10.1038/sj.bmt.1704026.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • B-Lymphocytes / virology*
  • Combined Modality Therapy
  • Cyclophosphamide / therapeutic use
  • Epstein-Barr Virus Infections / diagnosis*
  • Herpesvirus 4, Human / isolation & purification*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Lymphoproliferative Disorders / diagnosis*
  • Male
  • Middle Aged
  • Stem Cell Transplantation / adverse effects
  • Transplantation, Autologous
  • Vidarabine / analogs & derivatives*
  • Vidarabine / therapeutic use

Substances

  • Cyclophosphamide
  • Vidarabine
  • fludarabine